About the Company
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional compounds eno-4001 (phase three asset), eno-4002, eno-5001, and eno-3001 are in discovery stages for prevention relapse in colon cancer patients. enochian biosciences is headquartered in los angeles, california.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ENOB News
Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes
Dr. Serhat Gumrukcu, co-founder and the largest shareholder of Renovaro's predecessor, Enochian BioSciences, was charged with murder. Despite Gumrukcu's troubled past, Renovaro continued to work ...
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
(NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it has entered into a ...
Anderson Wittekind William's Net Worth
Who is Anderson Wittekind William? Anderson Wittekind William has an estimated net worth of $24.6 Million. This is based on reported shares in Enochian Biosciences Inc.
Statement of Renovaro Inc
and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. Enochian Biosciences NewsMORE Related Stocks ...
Renovaro Biosciences Inc (RENB)
The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.
Castle Biosciences, Inc. (NASDAQ:CSTL): Are Analysts Optimistic?
With the business potentially at an important milestone, we thought we'd take a closer look at Castle Biosciences, Inc.'s (NASDAQ:CSTL) future prospects. Castle Biosciences, Inc., a commercial ...
Aptose Biosciences Inc APTO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Pacira BioSciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Assembly Biosciences Inc ASMB
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shareholders are probably feeling a little disappointed, since its shares fell 4.1% to US$44.55 in the week after its latest full-year results. It looks like ...
Forte Biosciences Inc.
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic ...
CTKB Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and ...
Loading the latest forecasts...